The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet-Reference-Cited by-同舟云学术

The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet

Published:2016-11-19 Issue:2 Volume:60 Page:364-376
ISSN:0012-186X
Container-title:Diabetologia
language:en
Short-container-title:Diabetologia

Author:

Han Ji Hye,Oh Tae Jung,Lee Ghayoung,Maeng Hyo Jin,Lee Dong Hwa,Kim Kyoung Min,Choi Sung Hee,Jang Hak Chul,Lee Hye Seung,Park Kyong Soo,Kim Young-Bum,Lim Soo

Funder

Boehringer Ingelheim Fonds

Korea Diabetes Association

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00125-016-4158-2.pdf

Reference51 articles.

1. Kanai Y, Lee WS, You G, Brown D, Hediger MA (1994) The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest 93:397–404

2. Ehrenkranz JR, Lewis NG, Kahn CR, Roth J (2005) Phlorizin: a review. Diabetes Metab Res Rev 21:31–38

3. Kahn BB, Shulman GI, DeFronzo RA, Cushman SW, Rossetti L (1991) Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. J Clin Invest 87:561–570

4. Chasis H, Jolliffe N, Smith HW (1933) The action of phlorizin on the excretion of glucose, xylose, sucrose, creatinine and urea by man. J Clin Invest 12:1083–1090

5. Vallon V (2015) The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus. Annu Rev Med 66:255–270

Cited by 215 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Sodium Glucose Co-Transporter 2 Inhibitors in Atrial Fibrillation: A Comprehensive Review;Journal of Clinical Medicine;2024-09-12

2. The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-10

3. Empagliflozin attenuates epithelial-to-mesenchymal transition through senescence in peritoneal dialysis;American Journal of Physiology-Renal Physiology;2024-09-01

4. SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art;American Journal of Cardiovascular Drugs;2024-08-24

5. Longitudinal assessment of coronary plaque regression related to sodium–glucose cotransporter-2 inhibitor using coronary computed tomography angiography;Cardiovascular Diabetology;2024-07-22